Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Lenalidomide efficacy in activated B‐cell‐like subtype diffuse large B‐cell lymphoma is dependent upon IRF 4 and cereblon expression

Open access
Zhang, Ling‐Hua, Kosek, Jolanta, Wang, Maria, Heise, Carla, Schafer, Peter H., Chopra, Rajesh · 2013 · British Journal of Haematology

Abstract

Summary: Durable responses with lenalidomide monotherapy have been reported in patients with non‐Hodgkin lymphoma. In relapsed/refractory diffuse large B‐cell lymphoma (DLBCL), higher responses were observed in the activated B‐cell‐like (ABC) subtype than in the germinal centre B‐cell‐like subtype. Herein, the molecular mechanisms involved in the differential efficacy of lenalidomide in DLBCL subtypes were investigated. Using DLBCL cell lines, lenalidomide treatment was found to preferentially suppress proliferation of ABC‐DLBCL cells in vitro and delay tumour growth in a human tumour xenograft model, with minimal effect on non‐ABC‐DLBCL cells. This tumouricidal effect was associated with downregulation of interferon regulatory factor 4 (IRF 4), a hallmark of ABC‐DLBCL cells. IRF 4 inhibition by lenalidomide induced downregulation of B‐cell receptor (BCR)‐dependent NF‐κB. Whereas IRF 4‐specific small, interfering RNA mimicked the effects of lenalidomide reducing NF‐κB activation, IRF 4 overexpression enhanced NF‐κB activation and conferred resistance to lenalidomide. These findings indicate the crucial role of IRF 4 inhibition in lenalidomide efficacy in ABC cells. Furthermore, lenalidomide‐induced IRF 4 downregulation required the expression of cereblon, a molecular target of lenalidomide. Taken together, these findings suggest that lenalidomide has direct antitumour activity against DLBCL cells, preferentially ABC‐DLBCL cells, by blocking IRF 4 expression and the BCR‐NF‐κB signalling pathway in a cereblon‐dependent manner.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bjh.12172

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 167

Metadata

Authors
Zhang, L., Kosek, J., Wang, M., Heise, C., Schafer, P. H., & Chopra, R.
Venue
British Journal of Haematology
Publisher
Wiley
Published
2012-12-18
Volume
160
Issue
4
Pages
487-502
ISSN
  • 0007-1048 (ISSN-L)
  • 1365-2141
OpenAlex
W2077848703
Cited by
167
References
3
FWCI
7.69
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Lenalidomide efficacy in activated B‐cell‐like subtype diffuse large B‐cell lymphoma is dependent upon IRF 4 and cereblon expression. https://app.cochat.ai/papers/10.1111/bjh.12172
The paper
Zhang, L., Kosek, J., Wang, M., Heise, C., Schafer, P. H., & Chopra, R. (2013). Lenalidomide efficacy in activated B‐cell‐like subtype diffuse large B‐cell lymphoma is dependent upon IRF 4 and cereblon expression. British Journal of Haematology. https://doi.org/10.1111/bjh.12172

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.